证券日报网讯 11月14日晚间，长江证券发布公告称，公司发行不超过200亿元公司债券已获得中国证券 监督管理委员会"证监许可〔2025〕2145号"文注册。根据《长江证券股份有限公司2025年面向专业投资 者公开发行公司债券（第四期）发行公告》，长江证券股份有限公司2025年面向专业投资者公开发行公 司债券（第四期）（简称"本期债券"）发行规模为不超过30.00亿元（含），发行价格为每张100元，采 取网下面向专业机构投资者询价配售的方式。本期债券发行时间为2025年11月13日至2025年11月14日， 最终网下实际发行数量为30亿元，最终票面利率为1.93%，认购倍数为2.62。发行人的董事、监事、高 级管理人员、持股比例超过5%的股东以及其他关联方无参与认购情况。本期债券的主承销商中信建投 证券股份有限公司、中信证券股份有限公司、华泰联合证券有限责任公司及其关联方合计认购8.30亿 元。前述报价公允、程序合规。 （文章来源：证券日报） ...

Core Viewpoint - The company, Shengke Nano, announced a change in the representative responsible for the continuous supervision of its initial public offering (IPO) due to the previous representative's job change [1] Group 1 - Shengke Nano received a notice from its sponsor, Huatai United Securities, regarding the replacement of the IPO supervising representative [1] - The former supervising representative, Mr. Li Wei, is unable to continue due to a job change [1] - Mr. Sun Tianchi will take over the responsibilities of continuous supervision for the IPO [1]

Core Points - Yingjixin (688209.SH) closed at 20.83 yuan, with a decline of 1.37%, resulting in a total market capitalization of 8.967 billion yuan [1] - The stock is currently in a state of decline since its initial public offering (IPO) [1] Summary by Sections Company Overview - Yingjixin was listed on the Shanghai Stock Exchange's Sci-Tech Innovation Board on April 19, 2022, with an issuance price of 24.23 yuan per share [1] - The company issued 42 million new shares, accounting for 10% of the total share capital post-issuance [1] Fundraising Details - The total amount raised was 1.018 billion yuan, with a net amount of 907 million yuan after expenses [1] - The actual net fundraising amount exceeded the original plan by 507 million yuan [1] - The initial fundraising plan was set at 401 million yuan, intended for projects related to power management chip development, fast charging chip development, and working capital [1] Underwriting Information - The lead underwriter for Yingjixin is Huatai United Securities Co., Ltd., with representatives Zhang Peng and Tian Lai [1] - The total issuance costs (excluding tax) amounted to 110.265 million yuan, with Huatai United Securities receiving 90.7004 million yuan in underwriting and sponsorship fees [1]

Core Points - The company announced a change in the continuous supervision sponsor representative for its non-public stock issuance project due to personal work changes of the previous representative [1][2] - The new representatives are Chen Qinlei and Wang Rui, with Wang Rui taking over the responsibilities from Meng Chao [2] - The company expressed gratitude for Meng Chao's contributions during his tenure [2] Summary of Non-Public Issuance Fund Management - The company approved the use of up to 170 million RMB of idle funds from the non-public stock issuance for cash management, investing in safe and liquid principal-protected products [5] - The investment period is set for twelve months, from April 30, 2025, to April 29, 2026, with the funds allowed to be rolled over within this period [5] - As of November 12, 2025, the remaining balance of the idle funds in principal-protected financial products is 56 million RMB, with no overdue funds reported [6]

Core Viewpoint - MaiPu Medical (301033) has received acceptance from the Shenzhen Stock Exchange for its application to issue shares for asset acquisition, indicating a strategic move to enhance its asset base and financial position [1] Group 1 - The company plans to raise a total of 134 million yuan through this issuance [1] - Huatai United Securities Co., Ltd. is appointed as the independent financial advisor for this issuance [1]

Group 1 - The company has changed its continuous supervision sponsor representative due to the work transfer of the previous representative, Meng Chao, with Hu Mengjie now taking over the responsibilities [1][2] - The new sponsor representative, Hu Mengjie, is a deputy director in the investment banking business line at Huatai United Securities and a certified public accountant, with experience in significant asset transactions and capital raising projects [4] Group 2 - The company has terminated a fundraising project related to the production of medicinal glass bottles due to various external factors affecting market demand and has decided to permanently supplement its working capital with the remaining funds from this project [5][6] - The remaining funds amount to approximately RMB 285.27 million and have been transferred to the company's general bank account for operational use [9][11] - The company has completed the cancellation of the fundraising accounts associated with the terminated project [10][11]

Core Points - Yijiahe Technology Co., Ltd. announced a change in the continuous supervision representative for its non-public stock issuance project [2] - Huatai United Securities continues to fulfill its supervisory obligations regarding the use of raised funds, as the funds have not yet been fully utilized [2] - Wang Rui has been appointed to replace Meng Chao as the continuous supervision representative due to Meng Chao's personal work changes [2]

Core Viewpoint - Jiangsu Henghui Security Group Co., Ltd. has announced a change in the designated sponsor representatives for its ongoing supervision of the issuance of convertible bonds and listing on the ChiNext board [2] Group 1 - The company received a letter from Huatai United Securities regarding the replacement of the sponsor representatives for the ongoing supervision of its convertible bond issuance [2] - The original designated representatives, Ding Lubin and Meng Chao, were responsible for the supervision until December 31, 2026 [2] - Meng Chao will no longer serve as a sponsor representative due to a job change, and Kong Yinghao will take over his responsibilities [2]

Core Points - The company, Jiangsu Taimusi Textile Technology Co., Ltd., announced a change in its continuous supervision sponsor representative for its initial public offering (IPO) [1] - The previous sponsor representative, Meng Chao, is no longer able to continue due to job changes, and the new representative, Jiang Lei, has been appointed to take over [1] - The legal continuous supervision period for the company lasts until December 31, 2024, as the funds raised from the IPO have not yet been fully utilized [1] Summary by Sections - **Company Announcement** - Jiangsu Taimusi received a letter from Huatai United Securities regarding the change of its IPO continuous supervision sponsor representative [1] - The company is required to ensure orderly supervision as per legal and regulatory requirements [1] - **New Sponsor Representative** - Jiang Lei has been appointed as the new continuous supervision sponsor representative, replacing Meng Chao [1] - Jiang Lei possesses considerable experience in investment banking, indicating his capability to fulfill the role [1] - **Supervision Period** - The continuous supervision period is set to last until December 31, 2024, due to unutilized IPO funds [1]

格隆汇11月12日丨中金公司(03908.HK)公告，中国国际金融股份有限公司面向专业投资者公开发行不超 过200亿元(含200亿元)永续次级债券已获得中国证券监督管理委员会《关于同意中国国际金融股份有限 公司向专业投资者公开发行永续次级公司债券注册的批复》(证监许可【2025】2290号)。本次债券由华 泰联合证券有限责任公司和兴业证券股份有限公司承销，其中中国国际金融股份有限公司2025年面向专 业投资者公开发行永续次级债券(第一期)(以下简称"本期债券")发行规模为不超过人民币30亿元(含30亿 元)。本期债券票面利率询价区间为1.70%-2.70%。本期债券票面利率将根据网下询价簿记结果，由簿记 管理人按照国家有关规定协商一致在利率询价区间内确定。 2025年11月12日，主承销商在网下向投资者进行了票面利率询价。根据网下投资者询价结果，最终确定 本期债券的票面利率为2.23%。 ...